Prometheus or Dr Frankenstein?
DR Manmohan Singh, who passed away at 92 last week, will be remembered in contrarian ways. As finance minister and as prime minister, he condemned ‘left wing extremism’ as the biggest internal…
A poet’s odyssey
SHORTLY after the British poet laureate Ted Hughes died in 1998, it was rumoured that the shortlist for a successor included Tony Harrison. Unlikely as that might have been, given…
The long road to excellence
A few months ago, I attended a meeting discussing the inauguration of a new educational institution, an ambitious project aimed at creating something of lasting value for academia in Pakistan.…
As bitcoin soars, luxury brands consider accepting crypto payments
Bitcoin’s soaring value has caught the attention of high-end fashion brands and retailers, prompting further interest in offering cryptocurrencies as a means of payment to tap in to fresh pockets…
Bracing for Trump tariffs, China’s Xi makes diplomatic push at global summits
In his first global meetings since Donald Trump was reelected to lead the US, Chinese President Xi Jinping went on a diplomatic offensive, hedging against expected new tariffs and preparing…
Rehashing GDPR
DESPITE numerous attempts to introduce a robust data protection law that values the privacy of individuals and encourages growth, the proposed law on data protection fails to align the expectations…
Election 2024: a new Sharif era?
Since Imran Khan’s mess-ups are not as forgivable as the wrongs done by Nawaz Sharif circa 99 (and even circa 2017-18), the rejuvenation of the Sharif family’s era becomes an…
How do we navigate Generative AI?
The trickster and Titan Prometheus stole fire from the gods of Olympus and gifted it, together with the skills to use it, to humans. In this tale, fire is a…
Companies’ derivative bets to save on US debt costs turn riskier
A type of derivative trade that became popular with companies over the past year to save on interest costs is seeing demand slow, with risk increasing that the bets could…
Makers to raise drug prices in US this month
Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb , AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in…
